Biofrontera (BFRI) Balance Sheet: Assets & Liabilities

Biofrontera (BFRI) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Biofrontera reported total assets of $28.56M and total liabilities of $18.08M. Shareholders' equity was $10.48M, up 136.4% from $4.43M a year earlier. Total debt stood at $6.16M against $6.39M in cash and short-term investments, a net cash position of $231.00K. That puts debt-to-equity at 0.59, compared with 1.11 a year earlier.

Biofrontera Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Biofrontera Inc. (BFRI) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	6.39	5.91	1.34	17.21	24.55	24.55	8.08	7.30
Short-Term Investments	0.01	0.01	0.08	10.55	0.00	-	0.00	0.00
Cash & Short-Term Investments	6.39	5.91	1.42	27.76	24.55	24.55	8.08	7.30
Accounts Receivable	7.29	5.32	5.16	7.41	3.78	3.78	3.29	4.79
Inventory	1.43	6.65	10.91	7.17	4.46	4.46	7.09	10.48
Other Current Assets	2.97	2.83	5.58	0.81	13.63	0.76	1.12	0.90
Total Current Assets	18.08	20.70	23.08	43.14	46.42	46.42	19.58	23.47
Non-Current Assets
Property, Plant & Equipment (Net)	3.74	0.98	1.75	1.58	0.27	0.27	0.37	0.50
Long-Term Investments	0.20	0.00	0.00	0.00	2.81	-	0.00	0.00
Intangible Assets	2.65	0.04	2.63	3.03	3.45	3.45	3.87	4.29
Other Non-Current Assets	3.89	0.38	0.48	3.13	3.08	0.27	0.32	0.49
Total Non-Current Assets	10.48	1.40	4.86	7.74	6.80	6.80	4.56	5.28
Total Assets	28.56	22.10	27.93	50.88	53.22	53.22	24.14	28.75
Current Liabilities
Accounts Payable	1.86	1.86	3.31	1.28	0.66	0.66	1.51	7.81
Short-Term Debt	0.33	0.55	3.90	0.50	0.00	-	0.00	0.00
Accrued Liabilities	1.72	1.17	1.47	10.86	-	6.20	2.34	-
Deferred Revenue	0.00	0.00	0.00	6.94	3.24	3.24	0.00	0.00
Other Current Liabilities	9.71	9.62	0.69	12.18	9.94	0.83	2.91	3.93
Total Current Liabilities	11.90	12.02	18.09	20.89	13.84	13.84	4.42	11.74
Non-Current Liabilities
Long-Term Debt	5.83	4.37	0.80	0.85	0.00	-	0.00	38.20
Other Non-Current Liabilities	0.36	1.27	0.04	2.86	18.50	5.65	0.06	0.06
Total Non-Current Liabilities	6.19	5.65	5.05	6.11	28.05	28.05	13.89	47.19
Total Liabilities	18.08	17.67	23.14	27.01	41.88	41.88	18.31	58.93
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.02	0.02	0.01	0.00
Retained Earnings	-127.95	-117.41	-99.65	-79.52	-78.88	-78.88	-41.17	-30.18
Additional Paid-in Capital	138.41	121.83	104.44	103.40	90.20	90.20	46.99	0.00
Shares Outstanding	11.65	8.87	1.52	1.33	-	0.86	-	-
Total Stockholders' Equity	10.48	4.43	4.79	23.88	11.34	11.34	5.83	-30.18
Total Liabilities & Equity	28.56	22.10	27.93	50.88	53.22	53.22	24.14	28.75

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Biofrontera Balance Sheet

How much debt does Biofrontera have?

Biofrontera had total debt of $6.16M as of Dec 31, 2025, against $6.39M in cash and short-term investments. Its debt-to-equity ratio was 0.59. Total debt was $4.92M a year earlier.

What are Biofrontera's total assets?

Biofrontera reported total assets of $28.56M as of Dec 31, 2025, up 29.2% from $22.10M a year earlier. Total liabilities were $18.08M.

What is Biofrontera's shareholders' equity?

Biofrontera's shareholders' equity was $10.48M as of Dec 31, 2025, or about $0.90 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition